These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35836846)

  • 1. miRNA-612 suppresses ovarian cancer cell tumorigenicity by downregulating NOB1.
    Shi Z; Zhou X; Bao M; Jia R; Chu Y; Lin Y
    Am J Transl Res; 2022; 14(6):3904-3914. PubMed ID: 35836846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1.
    Lin Y; Xu T; Zhou S; Cui M
    Oncotarget; 2017 Nov; 8(60):101649-101658. PubMed ID: 29254193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-744 is downregulated in glioblastoma and inhibits the aggressive behaviors by directly targeting NOB1.
    Deng Y; Li Y; Fang Q; Luo H; Zhu G
    Am J Cancer Res; 2018; 8(11):2238-2253. PubMed ID: 30555741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-215 targets NOB1 and inhibits growth and invasion of epithelial ovarian cancer.
    Lin Y; Jin Y; Xu T; Zhou S; Cui M
    Am J Transl Res; 2017; 9(2):466-477. PubMed ID: 28337275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of microRNA-107 suppressed proliferation, migration, invasion, and the PI3K/Akt signaling pathway and induced apoptosis by targeting Nin one binding (NOB1) protein in a hypopharyngeal squamous cell carcinoma cell line (FaDu).
    Gao X; Fan X; Zeng W; Liang J; Guo N; Yang X; Zhao Y
    Bioengineered; 2022 Mar; 13(3):7881-7893. PubMed ID: 35294329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-139-3p suppresses growth and metastasis of glioblastoma via inhibition of NIN1/RPNI2 binding protein 1 homolog.
    Shi L; Yuan Y; Li HY
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4264-4274. PubMed ID: 31173298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-363-3p downregulation in papillary thyroid cancer inhibits tumor progression by targeting NOB1.
    Dong S; Xue S; Sun Y; Han Z; Sun L; Xu J; Liu J
    J Investig Med; 2021 Jan; 69(1):66-74. PubMed ID: 33077486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
    Hao T; Huang S; Han F
    Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-139-3p induces cell apoptosis and inhibits metastasis of cervical cancer by targeting NOB1.
    Huang P; Xi J; Liu S
    Biomed Pharmacother; 2016 Oct; 83():850-856. PubMed ID: 27505862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
    Zhang Y; Wang F; Wang L; Zhang Q
    World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).
    Li W; Liu M; Feng Y; Xu YF; Huang YF; Che JP; Wang GC; Yao XD; Zheng JH
    Br J Cancer; 2014 Sep; 111(6):1188-200. PubMed ID: 25010867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA‑744 suppresses cell proliferation and invasion of papillary thyroid cancer by directly targeting NOB1.
    Liu H; Guo J; Chai H; Meng X
    Mol Med Rep; 2019 Mar; 19(3):1903-1910. PubMed ID: 30628685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer.
    Kong R; Liu W; Guo Y; Feng J; Cheng C; Zhang X; Ma Y; Li S; Jiang J; Zhang J; Qiao Z; Qin J; Lu T; He X
    Oncol Rep; 2017 Oct; 38(4):2572-2580. PubMed ID: 28849232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of miRNA-192-5p contributes to N,N-dimethylformamide-induced hepatic apoptosis.
    Zhang Z; Zhu W; Liu Z; Liu Y; Chang C; Jiang H; Li R; Xiao Y; Chen W; Hu Q; Wang Q
    J Appl Toxicol; 2020 Dec; 40(12):1683-1693. PubMed ID: 32648274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-29c-3p regulates proliferation and migration in ovarian cancer by targeting KIF4A.
    Feng S; Luo S; Ji C; Shi J
    World J Surg Oncol; 2020 Dec; 18(1):315. PubMed ID: 33261630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer activity of NOB1-targeted shRNA combination with TRAIL in epithelial ovarian cancer cells.
    Lin Y; Xu T; Teng H; Cui M
    Int J Clin Exp Pathol; 2015; 8(9):10061-71. PubMed ID: 26617713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of long noncoding RNA XIST has anticancer effects on ovarian cancer through sponging miR-106a.
    Guo T; Yuan D; Zhang W; Zhu D; Xiao A; Mao G; Jiang W; Lin M; Wang J
    Hum Cell; 2021 Mar; 34(2):579-587. PubMed ID: 33400246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-18a suppresses ovarian carcinoma progression by targeting CBX7 and regulating ERK/MAPK signaling pathway and epithelial-to-mesenchymal transition.
    Zhao Y; Liu XL; Huang JH; Yin AJ; Zhang H
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5292-5302. PubMed ID: 32495862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.
    Li X; Chen W; Jin Y; Xue R; Su J; Mu Z; Li J; Jiang S
    Biochem Pharmacol; 2019 Mar; 161():98-112. PubMed ID: 30639456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of long non-coding RNA XIST upregulates microRNA-149-3p to repress ovarian cancer cell progression.
    Jiang R; Zhang H; Zhou J; Wang J; Xu Y; Zhang H; Gu Y; Fu F; Shen Y; Zhang G; Feng L; Zhang X; Chen Y; Shen F
    Cell Death Dis; 2021 Feb; 12(2):145. PubMed ID: 33542185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.